Literature DB >> 23396057

Control of cell adhesion and migration by podocalyxin. Implication of Rac1 and Cdc42.

Darío Fernández1, Angélica Horrillo, Carolina Alquezar, Consuelo González-Manchón, Roberto Parrilla, Matilde S Ayuso.   

Abstract

Podocalyxin (PODXL) is a type I membrane sialomucin, originally described in the epithelial cells (podocytes) of kidney glomeruli. PODXL is also found in extra-renal tissues and in certain aggressive tumors, but its precise pathophysiological role is unknown. Expression of PODXL in CHO cells enhances their adhesive, migratory and cell-cell interactive properties in a selectin and integrin-dependent manner. We aimed at defining the PODXL domains responsible for those cell responses. For this purpose we have analyzed the cell adhesion/migration responses to deletion mutants of human PODXL, and the correlation with the activities of Rac1 and Cdc42 GTPases. The results obtained indicate that integrity of the PODXL ectodomain is essential for enhancing cell adhesion but not migration, while the integrity of the cytoplasmic domain is required for both adhesion and migration. Deletion of the carboxy-terminal DTHL domain (PODXL-ΔDTHL) limited only cell adhesion. The activities of Rac1 and Cdc42 GTPases parallel the PODXL-induced variations in cell adhesion and migration. Moreover, silencing the rac1 gene virtually abolished the effect of PODXL in enhancing cell adhesion.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23396057     DOI: 10.1016/j.bbrc.2013.01.112

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Podocalyxin Expressed in Antigen Presenting Cells Promotes Interaction With T Cells and Alters Centrosome Translocation to the Contact Site.

Authors:  Laura Amo; Javier Díez-García; Estíbaliz Tamayo-Orbegozo; Natalia Maruri; Susana Larrucea
Journal:  Front Immunol       Date:  2022-05-31       Impact factor: 8.786

2.  A Comparative Analysis of the Lipoprotein(a) and Low-Density Lipoprotein Proteomic Profiles Combining Mass Spectrometry and Mendelian Randomization.

Authors:  Raphaëlle Bourgeois; Arnaud Girard; Nicolas Perrot; Jakie Guertin; Patricia L Mitchell; Christian Couture; Clarisse Gotti; Sylvie Bourassa; Paolo Poggio; Elvira Mass; Romain Capoulade; Corey A Scipione; Audrey-Anne Després; Patrick Couture; Arnaud Droit; Philippe Pibarot; Michael B Boffa; Sébastien Thériault; Marlys L Koschinsky; Patrick Mathieu; Benoit J Arsenault
Journal:  CJC Open       Date:  2020-12-03

3.  A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells.

Authors:  Bin Sheng Wong; Daniel J Shea; Panagiotis Mistriotis; Soontorn Tuntithavornwat; Robert A Law; Jake M Bieber; Lei Zheng; Konstantinos Konstantopoulos
Journal:  Cancer Res       Date:  2019-04-11       Impact factor: 13.312

4.  Serum podocalyxin levels correlate with carotid intima media thickness, implicating its role as a novel biomarker for atherosclerosis.

Authors:  Mayumi Shoji; Minoru Takemoto; Kazuki Kobayashi; Toshihiro Shoji; Satoka Mori; Jun-Ichi Sagara; Hiroyuki Kurosawa; Yoshiaki Hirayama; Kenichi Sakamoto; Takahiro Ishikawa; Masaya Koshizaka; Yoshiro Maezawa; Koutaro Yokote
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

5.  oxLDL promotes podocyte migration by regulating CXCL16, ADAM10 and ACTN4.

Authors:  Yuan Chen; Zhiyi Wang; Qian Li; Lichun Yu; Yanji Zhu; Jing Wang; Shuzhen Sun
Journal:  Mol Med Rep       Date:  2020-06-30       Impact factor: 2.952

6.  Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand.

Authors:  Osamu Ichii; Saori Otsuka-Kanazawa; Teppei Nakamura; Masaaki Ueno; Yasuhiro Kon; Weiping Chen; Avi Z Rosenberg; Jeffrey B Kopp
Journal:  PLoS One       Date:  2014-09-22       Impact factor: 3.240

7.  Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells.

Authors:  Estíbaliz Tamayo-Orbegozo; Laura Amo; Marta Riñón; Naiara Nieto; Elena Amutio; Natalia Maruri; Miren Solaun; Arantza Arrieta; Susana Larrucea
Journal:  Oncotarget       Date:  2017-09-27

8.  ADP-ribosylation factor-like 4C binding to filamin-A modulates filopodium formation and cell migration.

Authors:  Tsai-Shin Chiang; Hsu-Feng Wu; Fang-Jen S Lee
Journal:  Mol Biol Cell       Date:  2017-08-30       Impact factor: 4.138

9.  Epithelial-Mesenchymal Transition Induces Podocalyxin to Promote Extravasation via Ezrin Signaling.

Authors:  Julia Fröse; Michelle B Chen; Katie E Hebron; Ferenc Reinhardt; Cynthia Hajal; Andries Zijlstra; Roger D Kamm; Robert A Weinberg
Journal:  Cell Rep       Date:  2018-07-24       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.